Advances in Pulmonary Drug Delivery
portes grátis
Advances in Pulmonary Drug Delivery
Chi Lip Kwok, Philip; Chan, Hak-Kim
Taylor & Francis Ltd
06/2022
248
Mole
Inglês
9781032339757
15 a 20 dias
367
Descrição não disponível.
Foreword
Chapter 1: Inhaled proteins and peptides.
Chapter 2: Inhaled insulin: More compelling than ever.
Chapter 3: Inhaled therapeutic siRNA for the treatment of respiratory diseases.
Chapter 4: New molecules to treat asthma and COPD.
Chapter 5: Inhaled anti-cancer agents.
Chapter 6: Inhaled countermeasures for respiratory tract viruses.
Chapter 7: Pulmonary delivery of antibiotics for respiratory infections.
Chapter 8: Inhaled liposomes.
Chapter 9: Inhaled traditional Chinese medicine for respiratory diseases.
Chapter 10: Bronchoprovocation tests for evaluation of drug efficacy in asthma.
Chapter 1: Inhaled proteins and peptides.
Chapter 2: Inhaled insulin: More compelling than ever.
Chapter 3: Inhaled therapeutic siRNA for the treatment of respiratory diseases.
Chapter 4: New molecules to treat asthma and COPD.
Chapter 5: Inhaled anti-cancer agents.
Chapter 6: Inhaled countermeasures for respiratory tract viruses.
Chapter 7: Pulmonary delivery of antibiotics for respiratory infections.
Chapter 8: Inhaled liposomes.
Chapter 9: Inhaled traditional Chinese medicine for respiratory diseases.
Chapter 10: Bronchoprovocation tests for evaluation of drug efficacy in asthma.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
DPI;pulmonary drug development;Cf Patient;aeorsols;Inhaled Corticosteroids;inhaled drugs;TCM Injection;pulmonard disease;COPD Patient;drug delivery systems;FENO Level;lungs;Delivery System;Inuenza Virus;Inhaled Antibiotics;Inuenza Vaccines;AHR;Airway Hyperresponsiveness;Allergen Inhalation Challenge;ECP Level;Allergen Challenge Model;Liposomal Products;Pulmonary Safety;FEV1 Fall;Methacholine PC20;Mannitol Group;Hydrophobic Fatty Acid Tails;Inhaled Insulin Product;TOBI Podhaler;Methacholine Inhalation Challenge;Inhale Gm CSF
Foreword
Chapter 1: Inhaled proteins and peptides.
Chapter 2: Inhaled insulin: More compelling than ever.
Chapter 3: Inhaled therapeutic siRNA for the treatment of respiratory diseases.
Chapter 4: New molecules to treat asthma and COPD.
Chapter 5: Inhaled anti-cancer agents.
Chapter 6: Inhaled countermeasures for respiratory tract viruses.
Chapter 7: Pulmonary delivery of antibiotics for respiratory infections.
Chapter 8: Inhaled liposomes.
Chapter 9: Inhaled traditional Chinese medicine for respiratory diseases.
Chapter 10: Bronchoprovocation tests for evaluation of drug efficacy in asthma.
Chapter 1: Inhaled proteins and peptides.
Chapter 2: Inhaled insulin: More compelling than ever.
Chapter 3: Inhaled therapeutic siRNA for the treatment of respiratory diseases.
Chapter 4: New molecules to treat asthma and COPD.
Chapter 5: Inhaled anti-cancer agents.
Chapter 6: Inhaled countermeasures for respiratory tract viruses.
Chapter 7: Pulmonary delivery of antibiotics for respiratory infections.
Chapter 8: Inhaled liposomes.
Chapter 9: Inhaled traditional Chinese medicine for respiratory diseases.
Chapter 10: Bronchoprovocation tests for evaluation of drug efficacy in asthma.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
DPI;pulmonary drug development;Cf Patient;aeorsols;Inhaled Corticosteroids;inhaled drugs;TCM Injection;pulmonard disease;COPD Patient;drug delivery systems;FENO Level;lungs;Delivery System;Inuenza Virus;Inhaled Antibiotics;Inuenza Vaccines;AHR;Airway Hyperresponsiveness;Allergen Inhalation Challenge;ECP Level;Allergen Challenge Model;Liposomal Products;Pulmonary Safety;FEV1 Fall;Methacholine PC20;Mannitol Group;Hydrophobic Fatty Acid Tails;Inhaled Insulin Product;TOBI Podhaler;Methacholine Inhalation Challenge;Inhale Gm CSF
